OpenAlex
PricingAboutJobs
Log inGet started
Work

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

HTML

Year: 2017
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1615712
Authors: Franco Cosmi, Roberto Laini, Antonio Nicolucci
Institutions: Research Medical Center, Novo Nordisk (Denmark), Mario Negri Institute for Pharmacological Research, Center for Outcomes Research and Clinical Epidemiology
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: semaglutide, type 2 diabetes, cardiovascular outcomes, GLP-1 receptor agonists, liraglutide, insulin use, SUSTAIN 6 trial, LEADER trial, cardiovascular safety, heart failure, renal failure, hypoglycemia
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk Fonden
Awards: G1551214306, G2790715585, G4899559972
OpenAlex ID: W3049003652
Cites: 9
Cited by: 145
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security